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The immune response of mice to  the branched multichain synthetic polypeptide 
poly-L(Tyr,Glu)-poly-D,L-Ala--poly-L-Lys  [(T,G)-A--L]  I  is  under  the  control  of  a 
cedominant gene, It-l,  which maps near the middle of the major histocompatibillty 
(11-2) complex (1). H-2  bib mice given a primary challenge of (T, G)-A--L in adjuvant 
and  a  secondary challenge of  (T, G)-A--L in  saline produce large amounts  of anti- 
(T,G)-A--L antibody.  In  contrast,  H-2  ~/k  mice  so  immunized  produce  markedly 
lower amounts  (2).  Responses to many other antigens have also been  shown  to be 
controlled by  immune  response genes linked to  tt-2  (3).  Histocompatibility-]inked 
immune responses have been demonstrated in other species as well. In guinea pigs, 
the ability to respond to poly-L-lysine (PLL)  or haptens bound to PLL is linked to 
the guinea pig major histocompatibility locus  (4).  Nonresponder strain guinea pigs 
can be made to produce large amounts of anti-dinitrophenyl (DNP)-PLL antibodies, 
if they  are  challenged with  DNP-PLL  electrostatically coupled to  foreign albumin 
carriers  (5).  Nonresponder  animals  first  made  tolerant  to  bovine  serum  albumin 
(BSA) and then challenged with DNP-PLL-BSA are unable to synthesize anti-DNP- 
PLL antibody. This indicates that nonresponder animals are capable of making anti- 
hapten antibody only when the hapten is attached to an immunologically recognizable 
carrier (6). These data can be interpreted as suggesting that the PLL gene regulates 
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antigen  recognition,  rather  than  the  ability  to  synthesize  a  particular  antibody 
specificity. 
In  analogous  studies  in  mice,  nonresponder  mice  immunized  with  (T,G)-A--L 
electrostatically complexed to the carrier methylated bovine serum albumin (MBSA) 
in adjuvant will produce anti-(T,G)-A--L antibody in amounts  equal to  responder 
mice  immunized  with  (T,G)-A--L  or  MBSA-(T,G)-A--L in  adjuvant  (2).  Hence 
nonresponders have  the  capacity to  make  the  anti-(T,G)-A--L antibody, provided 
(T, G)-A--L is attached to a  recognizable carrier. These data fit the hypothesis that 
the Ir-1  gone is not expressed in  the bone marrow-derived antibody-producing cell, 
or B  cell, but instead is involved in antigen recognition. 
Further evidence as to the nature of the Ir-1 gone effect can be found if one uses an 
immunizing  regimen  of  (T,G)-A--L in  saline  only.  Here  H-2  bib  and  //-2  klk  mice 
produce  an  approximately  equal  IgM  anti-(T,G)-A--L  antibody  response  after 
primary  challenge  with  (T,G)-A--L; however,  upon  secondary  antigen  challenge, 
H-2 bib mice will shift from IgM to IgG antibody production, while H-2 k/k mice will 
neither shift nor  produce another peak of  IgM anti-(T,G)-A--L antibody (7). This 
suggests that the Ir-1 gone affects the shift from IgM to IgG production. This could 
involve an actual switching of IgM-producing cells to IgG production, or could involve 
activation of a  population of antibody-producing precursor cells committed to pro- 
ducing IgG. There are currently no  data to  distinguish between  these two possible 
mechanisms. 
It has also been demonstrated that thymectomized H-2 ~b mice are functional non- 
responders, that is, they have an intact IgM response after primary challenge with 
(T, G)-A--L in saline, but they will not shift from IgM to IgG production after second- 
ary challenge with (T, G)-A--L in  saline (8). Since thymectomy converts a  responder 
into a phenotypic nonresponder, it appears likely that the Ir-1 gene is expressed at the 
level of the thymus-derived antigen-reactive lymphocyte, or T  cell. 
From  the  preceding  data  two  hypotheses  can  be  made.  First,  in  a  responder, 
challenge with  (T, G)-A--L activates T  cells, which then influence B  cells, causing a 
shift from IgM to IgG anti-(T,G)-A--L antibody production. In a  nonresponder no 
such T cell activation occurs, and consequently this shift does not occur. If one assumes 
the effect of activated T  cells on B  cells to be nonspecific, a second hypothesis can be 
made,  namely,  that  activation of T  cells in  nonresponder  mice by  a  process other 
than challenge with (T, G)-A--L may cause the shift from IgM to IgG production. One 
method of inducing T  cell activation is by means of a graft-versus-host (GVH) reaction 
(9). GVH reactions have been used in certain systems to substitute for carrier-reactive 
T  cells in the generation of a secondary antibody response. This has been accomplished 
in guinea pigs through the transfer into DNP-ovalbumin (OVA)-primed recipients of 
allogeneic or semiallogeneic cells (10,  11). In mice an allogeneic cell transfer has been 
used to activate a clone of anti-DNP antibody-producing cells (12). 
The  present  report  describes  the  results  of  inducing  a  GVH  reaction  in 
(T,G)-A--L nonresponder mice at the time of challenge with  aqueous  (T,G)- 
A--L.  Consistent  with  the  stated  hypotheses,  GVH  induction  was  associated 
with  the  production  of  IgG  anti-(T,G)-A--L antibody in  the  absence  of  the 
responder It-1  allele. JOHN  C.  ORDAL  AND  F.  CARL  GRUMET  1197 
Materials and Methods 
Mice.--C3H.Q  mice were kindly provided  by  Dr.  Donald  C.  Shreffler  (Department  of 
Human Genetics, University of Michigan School of Medicine, Ann Arbor, Mich.). C3H/DiSn 
and (C3H. Q X C3H/DiSn)F 1 mice were bred at Stanford. The C3H. Q strain is congenic with 
the C3H/HeJ strain,  C3H.Q being H-2  qlq and  C3H/HeJ being H-2  klk. The C3H/HeJ and 
C3H/DiSn strains are closely related, coming originally from the same ancestor line. 
Antigens,  Immunization  Procedures,  and  Antibody  Determinations.--(T , G)-A--L  is  a 
branched,  mulfichain,  synthetic  polypeptide which has  been described  previously  (13, 14). 
(T,G)-A--L 52 (mol wt 180,000) was diluted in phosphate-buffered sa]ine  (PBS) to a concen- 
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FIGS.  1 a  and  1 b.  Total  (  )  and  2-mercaptoethanol-resistant  (MeR)  (  .....  )  antibody 
response of C3H/DiSn (//-2  k/k) mice to (a) primary (day 0) challenge with 10 ~g (T, G)-A--L 
intraperitoneally and (b) primary (day 0) and secondary (day 7) challenge with 10 ~g (T, G)- 
A--L intraperitoneally. Each point represents a plasma pool of five mice. 
tration of 170 ~g/ml; for all immunizations, 0.06  ml (10 ~g)  was injected intraperitoneally. 
Mice were bled from the tail or from the retroorbital sinus to obtain plasma for antibody deter- 
minations. Equal samples of heparinized plasma from each individual mouse in a group were 
pooled and stored frozen until assayed by titration. 
Antibody was assayed at a plasma dilution of 1/25 in BSA by using a modified Farr assay as 
described earlier (7).  125I-labeled (T,G)-A--L 52 (0.008/~g/ml)  and  125I-labeled  (T,G)-A--L 
509  (0.01  g/ml) were used interchangeably  as the labeled antigens.  Titers of 2-mercapto- 
ethanol  (2-Me)-resistant  (IgG) antibody were determined by incubating plasma pools with 
equal volumes of 0.1 •  2-Me at 37°C for 60 min and then diluting the mixture with BSA for 
titration. 
Preparation of Cells.--Spleen  and inguinal lymph node cells were teased through a wire mesh 
screen into a solution of minimal essential medium without NaHCOa (MEM) +  5% fetal calf 1198  GVH  INDUCTION  OF  SPECIFIC  IGG ANTIBODY  PRODUCTION 
serum  (FCS). The MEM and FCS were obtained from Grand Island Biological Co., Grand 
Island, N.Y. The MEM was made up in deionized water and to it was added  Na2PO4 and 
MgC12, each to a final concentration of O.001 ~. 
Ceils were dispersed with a Pasteur pipette and washed three times in MEM +  5% FCS, 
and then injected into the tail vein in a volume of 0.4 ml. Concentrations of cell suspensions 
used for injection were determined by suspending a 5 ~1 sample in 20 ml of filtered 37% form- 
aldehyde-saline solution  to which 0.1  mg saponin had  been added,  and  then  counting in a 
Model B Coulter Counter (Coulter Electronics, Inc., Hialeah, Fla.) with a 100 ~ aperture. 
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FIGS. 2 a  and  2 b.  Total  (----)  and MeR  (  .....  )  antibody  response  of  (C3H.Q  X  C3H/ 
DiSn)F1 (H-2 k/~) mice given 88 X  106 H-2  klq lymphoid cells intravenously on day 0 and  (a) 
primary  (day 0)  challenge with 10  t~g (T, G)-A--L intraperitoneally and  (b) primary  (day 0) 
and secondary  (day  7)  challenge with  10 ~g  (T,G)-A--L intraperitoneally.  Each point rep- 
resents a plasma pool of five mice. 
RESULTS 
Figs.  1 a  and  1 b show the total antibody  and 2-Me-resistant  (IgG)  antibody 
made  against  (T,G)-A--L  in  C3H/DiSn  (H-2  k/k)  mice  after  primary  and  sec- 
ondary  antigen  challenge.  In both  cases  the  antibody  produced  was  entirely 
IgM. After secondary antigen challenge,  there was no shift to IgG production, 
as  would  occur  in  responder  C3H.SW  (H-2  bib)  mice  (7);  rather,  there  was 
merely  a  transient  dip  in  the  IgM  titer.  Similar  curves  were  obtained  for 
C3H.Q  and  (C3H.Q  X  C3H/DiSn)F1  mice  challenged  once  or  twice  with JOHN  C.  ORDAL AND  ~'.  CARL  GRUMET  1199 
(T, G)-A--L; i.e.  the response was limited to the production of IgM antibody, 
and no shift to IgG antibody occurred after secondary challenge. 
Figs.  2 a-2 d  show the response of F1 mice after the injection of syngeneic 
(H-2  k/q) lymphoid cells and challenge with (T, G)-A--L. The results are virtually 
identical with the results for the C3H/DiSn  (//-2  k/k) mice (given antigen but 
no syngeneic cells)  in  Figs.  1 a  and  1 b.  Again  only IgM  antibody was  pro- 
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FIGS.  2 c and  2 d.  Total  (  )  and  MeR  (  .....  )  antibody  response of (C3H.Q  X  C3H/ 
DiSn)F1  (tt-2 k/a)  mice given 130  X  106 H-2  klq  lymphoid cells intravenously on day O and 
142 X  106 H-2  k/q lymphoid cells intravenously on day 7 and (c) primary (day 0) challenge with 
10 ~g (T,G)-A--L intraperitoneally and  (d) primary (day 0) and secondary  (day 7) challenge 
with 10 ~g (riP,  G)-A--L intraperitoneally. Each point represents a plasma pool of three to five 
mice. 
duced  and  there  was  no  shift  to  IgG  antibody production  after  secondary 
challenge. 
In  contrast  to  the effect of the  transfer of syngeneic (H-2  klq) cells  into  FI 
mice, Figs. 3 a-3 d show the response in F1 mice to challenge with (T,G)-A--L 
when given at  the same  time  as the  transfer of parental  (H-2  klk) cells.  Figs. 
3 a and 3 b show groups of mice receiving 72  X  l06 H-2  ~lk lymphoid cells at  the 
same  time  as  primary  challenge  with  (T,G)-A--L.  Both  groups  had  higher 
peaks  of total  antibody than  the  FI mice receiving F1 cells;  moreover, both 1200  GVtI  INDUCTION  OF  SPECIFIC  IGG  ANTIBODY  PRODUCTION 
groups  produced  detectable  IgG  anti-(T,G)-A--L  antibody  (reaching  a  peak 
of about 20 %  on day 7). As shown in Fig. 3 b,  a  second challenge with  (T, G)- 
A--L had little  effect; in particular,  it did not elicit increased IgG anti-(T, G)- 
A--L antibody production. 
Figs. 3 c and 3 d  demonstrate the effect of the transfer of a  larger number of 
parental  cells  into  the  F1  at  the  same  time  as primary challenge with  (T,G)- 
H-2k/kcells 
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FIGS. 3 a and 3 b. Total (----) and MeR (  .....  ) antibody response of (C3H.Q X  C3H/ 
DiSn)F1 (H-2  k/q) mice given 72 X  106 H-g  kt~ lymphoid cells intravenously  on day 0 and  (a) 
primary (day 0) challenge with  10  g (T, G)-A--L intraperitoneally  and (b) primary  (day 0) 
and secondary  (day 7) challenge with  10 ug (T,G)-A--L intraperitoneally.  Each poin.t rep- 
resents a plasma pool of four or five mice. 
A--L. Here 150 X  106 cells were given on day 0, about twice as many as given 
to  those  groups shown in  Figs.  3 a  and  3 b.  The  result  once again  was  an  in- 
creased total antibody titer when compared with the F1 controls in Figs. 2 62  d. 
In  addition,  the  amount  of  IgG  anti-(T,G)-A--L  antibody  produced  was 
considerably greater  than  in the groups shown in Figs.  3 a  and 3 b,  which re- 
ceived  fewer  cells.  Again  the  highest  IgG  antibody  titers  (about  45 %)  were 
found on day 7, and the transfer of more parental  cells on day 7 with  or  with- 
out secondary antigen  challenge  did  not  stimulate  further  production  of IgG 
anti-(T, G)-A--L antibody. It is of interest  to note that in all of the F1 groups 
receiving  parental  cells  the  levels  of both  total  and  2-Me-resistant  antibody JOItN  C.  ORDAL  AND  F.  CARL  GRUMET  1201 
fell off rather quickly  after reaching their peak  and by day 20 were quite low 
in most cases. It is also important to note here that the IgG antibody produced 
was being made  after primary  challenge  with  (T,G)-A--L;  this  is in contrast 
to  normal  responder  mice,  in  which  10  #g  (T,G)-A--L  does  not  elicit  IgG 
antibody  production  until  after  secondary  challenge  (7). 
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FIGS.  3 c  and 3 d.  Total  (----)  and MeR  (  .....  )  antibody response  of  (C3H.Q  X  C3H/ 
DiSn)F1  (tt-2 klq)  mice given  150  X  106 H-2  klk lymphoid cells intravenously  on day  0  and 
208 X  106 t1-2  klk lymphoid cells intravenously on day 7 and (c) primary (day 0) challenge with 
10  I*g (T,G)-A--L intraperitoneaUy and (d) primary (day 0) and secondary  (day 7) challenge 
with 10/,g (T, G)-A--L intraperitoneally. Each point represents  a plasma pool of three to five 
mice. 
The  timing  between  the  transfer  of parental  cells  and  the  challenge  with 
antigen  is quite critical. This is demonstrated  in Fig. 4. Here parental  (II-2  k/k) 
cells  were given  to F1 recipients  7  days  before  antigen  challenge,  as  well as 
with both primary  and  secondary  antigen  challenges.  Not  only was there no 
IgG  antibody  produced,  but  also  total  (IgM)  antibody titers  were markedly 
reduced. 
Fig. 5 shows the effect of the transfer into F1 recipients of parental  (H-2  k/~) 
cells which have been previously  sensitized  to H-2q specificities.  Cell transfers 
were given with both the primary and secondary challenges with (T, G)-A--L. 
As can be seen, no IgG anti-(T,G)-A--L  antibody  was made,  and again total 
(IgM)  antibody production was sharply reduced. 1202  CVI~  INDUCTION  OF  SPECIFIC  IGG ANTIBODY  PRODUCTION 
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FIG. 4.  Total  (----)  and  MeR  (  ..... )  antibody  response  of  (C3H.Q  X  C3H/DiSn)F1 
(H-2  ktq) mice given H-2  k/k lymphoid cells intravenously on day  --7  (100 X  106 cells),  day 0 
(140  X  106 cells),  and day 7  (230 X  106 cells)  and primary  (day 0)  and secondary  (day 7) 
challenge with 10 ~g (T, G)-A-L intraperitoneally. Each point represents a plasma pool of five 
mice. 
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FIG. 5.  Total  (--)  and  MeR  (  .....  )  antibody  response  of (C3H.Q  X  C3H/DiSn)F1 
(1t-21:/q) mice given alloimmune  (primed  to H-2  q  specificides)  H-2  kl~ lymphoid  cells  intra- 
venously on day 0  (200 X  106 cells)  and day 7  (160 X  106 cells)  and primary  (day 0)  and 
secondary (day 7) challenge with 10 ~g (T, G)-A--L intraperitioneally. Each point represents a 
plasma pool of five mice. (The alloimmune cells were prepared as follows: 100  X  106 C3H .Q 
(1-1-2  qjq) spleen cells were injected intraperitoneally into C3H/DiSn (H-2  ~/k) recipients. 1 wk 
later these recipients were sacrificed  and their spleen cells [now alloimmune] used for injection 
into the F1 recipients.) 
DISCUSSION 
A  large  amount  of  data  is  available  to  support  the  concept  that  at  least 
two  cell  types  participate  in  the  generation  of  immune  responses  to  most 
antigens  (15).  One  of these  is  the bone  marrow-derived  precursor  of the  anti- 
body-producing  cell,  or B  cell.  The  other  cell  type,  which  does not  appear  to 
secrete  antibody,  is  the  thymus-derived  lymphocyte,  or  T  cell.  It  has  been JOHN  C.  ORDAL  AND  F.  CARL  GRUMET  1203 
suggested that,  in general, T  cells react with a  carrier moiety on the antigen 
involved in  a  given  immune  response,  while  B  cells  react  with  the  hapten 
moiety (15,  16).  This view is  given support  by findings in  mice  and  guinea 
pigs which show that genetic nonresponders to specific antigens can be made 
to produce anti-hapten antibody if the antigen involved is coupled to a recog- 
nizable carrier (2,  5). The concept of carrier-reactive T  cells and hapten-reac- 
tive B  cells  can  be invoked to  explain  the results found in  mice  challenged 
with  aqueous  (T,G)-A--L.  Specifically,  it  appears  that  the  production  of 
IgM anti-(T, G)-A-L antibody by B  cells is T  cell independent, but that the 
production of IgG anti-(T,G)-A--L antibody by B  cells requires T  cell recog- 
nition of the antigen (8). Presumably, in responders there exists a population 
of T  cells which  can  recognize a  carrier moiety on  (T,G)-A--L and  become 
activated  (and perhaps proliferate); the  activated T  cells may then interact 
with B  cells [which recognize haptenic determinants on (T, G)-A--L] via cell- 
to-cell contact or perhaps via a humoral factor (or perhaps both), and thereby 
induce  the  B  cells  to  produce  IgG  antibody.  Nonresponders,  on  the  other 
hand,  are  apparently  deficient  in  (T,G)-A--L-reactive  T  cells,  and  hence 
never shift to IgG anti-(T, G)-A--L antibody production. 
Given that nonresponders lack (T, G)-A--L-reactive T  cells, it can be postu- 
lated that  activation of nonresponder T  cells  by a  means other than  (T, G)- 
A--L may be possible,  and furthermore, that  these  activated T  cells may be 
able to cause the IgM  to IgG shift.  In  order to test this possibility,  a  GVH 
reaction was employed as a method of T  cell  activation (9).  Congenic H-2  kl*, 
H-2q/q,  and  H-2  klq mice [all  nonresponders  to  (T,G)-A--L]  were  used.  GVH 
reactions  were  induced  in  H-2  klq  recipients  by  injecting  parental  (H-2  klk) 
lymphoid cells.  The recipients were challenged with  (T,G)-A--L at  the time 
of cell  transfer,  and  this  resulted in  the production of IgG  anti-(T,G)-A--L 
antibody. 
This production of IgG anti-(T, G)-A--L antibody was found to be critically 
dependent  upon  the  timing  and  severity of the  GVH reaction  induced.  For 
instance,  the transfer of parental  (H-2  k/~) cells 1 wk before administration  of 
antigen  did not  elicit IgG  antibody production; indeed,  the  amount  of IgM 
antibody produced was sharply reduced. Also, when parental cells were given 
at the same time as (T, G)-A--L, the transfer of a larger number of cells elicited 
a  higher titer of IgG anti-(T, G)-A--L antibody. However, if the  GVH reac- 
tion was  too severe, such as in  the transfer of H-2  ~/k cells  from mice primed 
to  H-2q/q cells,  there was  no IgG antibody production and  again  total  (i.e., 
IgM)  antibody production was  diminished. These results suggest  that  T  cell 
activation  must  occur at  the  same  time  as  B  cell  exposure  to  (T, G)-A--L, 
and that  a  greater degree of T  cell activation exerts a  greater  ("helper") in- 
fluence  on  B  cells,  as  measured  by  the  production  of  IgG  anti-(T,G)-A--L 
antibody. Too severe a GVH reaction, however, may have a negative ("killer") 
effect on  B  cells,  reducing  antibody production  and  preventing  the  IgM  to 
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GVH  reactions  have  been  employed  in  other  systems  to  stimulate  the 
production of antibody against  certain antigens.  In  guinea pigs,  the transfer 
of strain 2 lymphoid cells into DNP-OVA-primed strain 13 recipients stimulates 
the  production of both  anti-DNP  and  anti-OVA  antibodies,  without further 
antigen  challenge  (10).  Moreover, these  recipients  are  capable  of generating 
a  marked  secondary  anti-DNP  response  when  challenged with  DNP-bovine 
gamma globulin (BGG) (10), or even with a DNP conjugate of the copolymer 
of  D-glutamic  acid  and  D-lysine  (DNP-D-GL)  which  is  normally  tolerigenic 
in  guinea pigs  (17).  These  data  suggest  that  this  "allogeneic effect" has  re- 
moved the requirement for carrier-specific T  cells.  Similar results are obtained 
in  a  system where parental  (strain  2)  lymphoid cells  are  injected into  (2  X 
13)F1  recipients (11). 
In  irradiated  CBA  mice,  the  transfer  of  allogeneic  (AKR)  cells  together 
with  an  anti-DNP  antibody-forming clone of CBA  lymphocytes will  elicit in 
that  clone  an  anti-DNP  response  after  challenge  with  DNP-OVA  (12).  If 
syngeneic  cells  are  used  instead  of  allogeneic  cells  in  the  transfer,  no  such 
anti-DNP  response occurs,  suggesting  that  the  allogeneic cells  serve as  a  re- 
placement for carrier-primed T  cells.  Consistent  with  this hypothesis, it was 
also found that  allogeneic cells  added to cells  from the clone pretreated with 
anti-0  and  complement  restore  the  production  of  anti-DNP  antibody  after 
challenge with DNP-BGG (12). 
It therefore appears that the requirement for host T  cells in certain immune 
responses can be circumvented by the use of allogeneic or semiallogeneic cells 
which  are  capable  of  recognizing host  histocompatibility  antigens.  In  non- 
responder nfice immunized with (T, G)-A--L, we have shown that a GVH reac- 
tion can induce the shift from IgM to IgG anti-(T,G)-A--L antibody produc- 
tion.  It  is  of  interest  to  note  that  this  shift  occurs  without  a  second  chal- 
lenge with  10 ttg  (T, G)-A--L. This differs from the kinetics of antibody pro- 
duction  in  responders,  where primary challenge with  10 ttg  (T, G)-A--L will 
not  elicit  IgG  anti-(T,G)-A--L  antibody production,  but  primary challenge 
with  100 ttg  (T, G)-A--L will.  It can be postulated that  in responder mice a 
primary challenge with  10/~g  (T, G)-A--L elicits  the  proliferation of T  cells 
which, when activated upon secondary challenge with 10/~g  (T,G)-A--L, are 
present  in  sufficient quantity  to  influence  (hapten-reactive)  B  cell  antibody 
production  (i.e.  cause  the  IgM  to  IgG shift).  In  this  model,  100 /zg  (T,G)- 
A--L into a responder would act as both a primary and a secondary challenge, 
that is,  enough antigen would still remain after the proliferation of T  cells to 
activate  these  cells.  Similarly,  the  induction  of  a  GVH  reaction  in  a  non- 
responder  may  activate  (by  recognition  of histocompatibility differences)  a 
large enough number of T  cells to enable the shift to IgG production to occur 
after primary challenge with  (T, G)-A--L. 
From these data,  it is impossible to say whether or not activated parental 
T  cells  stimulate the same B  cells  that activate them, or different ones,  or if 
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to postulate  that  the production of IgG anti-(T,G)-A--L antibody is  due to 
some nonspecific effect of the GVH reaction, such as an alteration in the "proc- 
essing"  of  antigen  by  macrophages,  which  somehow  "triggers"  B  cells.  As- 
suming an effect of parental T  cells on B cells, it is not known if these donor T 
cells can stimulate only host B cells, which appear foreign, or whether donor B 
cells  can be stimulated  as well.  Both donor H-2  k/* B  cells and host H-2  k/q B 
cells  may  be  making  IgG  anti-(T,G)-A--L  antibody.  The  nature  of  the  T 
cell interaction with  B  cells is  also unknown.  Direct cell-to-cell contact may 
be required between activated T  cells and B  cells  exposed to antigen,  and/or 
T  ceils  may release a  humoral factor which could influence nearby B  cells.  T 
cells in  GVH reactions are known to release a  number of nonantibody medi- 
ators  (18),  and it is possible that  one of these factors may stimulate  (T,G)- 
A--L-reactive B  ceils.  Regardless of the mechanism of the T  and B  cell inter- 
action,  the  data  presented  here  are  consistent  with  the  model  that  T  cell 
activation, whether induced by antigen  (in  a  responder)  or  a  GVH reaction 
(in a nonresponder) is required for the shift from IgM to IgG anti-(T, G)-A--L 
antibody production. 
SUMMARY 
The transfer of parental  (H-2  kjk) nonresponder lymphoid ceils into hetero- 
zygous (H-2  klq) nonresponder recipients at the time of primary challenge with 
aqueous  poly-L(Tyr,  Glu)-poly-D,L-Ala--poly-L-Lys [(T, G)-A--L]  elicited  the 
production  of both  IgM  and  IgG  anti-(T,G)-A--L  antibody.  Normally,  the 
production of IgG anti-(T, G)-A--L antibody is restricted to strains possessing 
the  responder Ir-1  allele.  The  timing  and  intensity  of  the  graft-versus-host 
(GVH) reaction required for this effect were found to be critical.  Injection of 
It-2  ~/k cells  into H-2  k/q recipients 1 wk before antigen  challenge did not elicit 
IgG  anti-(T,G)-A--L  antibody  production,  and  markedly  suppressed  IgM 
anti-(T,G)-A--L  antibody  production.  The  transfer  of  alloimmune  (H-2q- 
primed) H-2  klk cells  at the time of antigen challenge was also associated with 
no IgG and little IgM  anti-(T,G)-A--L antibody production. These data are 
consistent with the model that nonresponder thymus-derived lymphocytes (T 
cells)  activated in  a  GVH reaction can substitute for (T,G)-A--L-reactive T 
cells to induce a shift from IgM to IgG anti-(T,G)-A--L antibody production. 
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